Cholesterol-lowering prescription drugs Zetia, Vytorin found to have no medical benefit

Armen Hareyan's picture
Advertisement

A new study of cholesterol lowering prescription drugs Vytorin and Zetia concludes that Vytorin failed to slow the buildup of artery plaques more than a cheaper statin is certain to provoke questions among heart patients taking Vytorin or its sister drug Zetia.

Here's the bulletin from today's New York Times: an FDA-approved, prescription drug Zetia (and Vytorin)

Share this content.

If you liked this article and think it may help your friends, consider sharing or tweeting it to your followers.
Advertisement